
Aurora Cannabis Inc. (NASDAQ:ACB) reported its financial and operational results for the fourth quarter and fiscal year ending June 30, 2022, on Tuesday, revealing a net revenue of $50.2 million compared to the previous quarter's total cannabis net revenue of $50.4 million.
Medical cannabis net revenue totaled $36.6 million, representing a 4% increase from the prior year period and accounting for 72.8% of Aurora's quarterly consolidated net revenue.